Nutriband Financials
This page shows Nutriband (NTRBW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Minimal sales are not financing operations; new capital is sustaining a development-stage cost structure.
From FY2023 to FY2025, revenue stayed near$2.1M while R&D spending climbed from$982K to$3.1M and operating cash burn widened from-$3.0M to-$4.6M , so the company is scaling investment rather than scaling a proven sales engine. The reason liquidity still looks workable is that financing inflows of$8.5M in FY2025 more than offset that year's free cash outflow of-$4.7M .
The income statement and cash flow statement point the same way: FY2025's net loss of
This is also a low-capex burn model: capital spending was only
Financial Health Signals
Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Nutriband's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Nutriband passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Nutriband generates $0.62 in operating cash flow (-$5.1M OCF vs -$8.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Nutriband earns $-369.1 in operating income for every $1 of interest expense (-$8.3M vs $23K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Nutriband generated $2.0M in revenue in fiscal year 2026. This represents a decrease of 4.8% from the prior year.
Nutriband's EBITDA was -$8.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.8% from the prior year.
Nutriband reported -$8.2M in net income in fiscal year 2026. This represents an increase of 21.5% from the prior year.
Nutriband earned $-2.58 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 160.6% from the prior year.
Cash & Balance Sheet
Nutriband generated -$5.1M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 8.9% from the prior year.
Nutriband held $4.0M in cash against $0 in long-term debt as of fiscal year 2026.
Nutriband had 12M shares outstanding in fiscal year 2026. This represents an increase of 9.0% from the prior year.
Margins & Returns
Nutriband's gross margin was 27.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 6.9 percentage points from the prior year.
Nutriband's operating margin was -408.4% in fiscal year 2026, reflecting core business profitability. This is up 72.3 percentage points from the prior year.
Nutriband's net profit margin was -404.1% in fiscal year 2026, showing the share of revenue converted to profit. This is up 85.9 percentage points from the prior year.
Nutriband's ROE was -137.4% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 68.0 percentage points from the prior year.
Capital Allocation
Nutriband invested $1.9M in research and development in fiscal year 2026. This represents a decrease of 39.4% from the prior year.
Nutriband invested $5K in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 94.2% from the prior year.
NTRBW Income Statement
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $433K+8.2% | $401K+15.8% | $346K-44.4% | $622K-6.7% | $667K+3.9% | $642K-0.5% | $646K+45.8% | $443K |
| Cost of Revenue | $237K-24.1% | $312K+12.3% | $278K-40.4% | $466K+12.1% | $415K+16.6% | $356K-21.6% | $455K+33.3% | $341K |
| Gross Profit | $197K+121.3% | $89K+29.8% | $69K-56.3% | $157K-37.7% | $252K-11.9% | $286K+49.7% | $191K+88.1% | $102K |
| R&D Expenses | $247K+31.5% | $188K-58.9% | $457K-18.7% | $563K-17.7% | $683K+39.5% | $490K-44.4% | $881K+13.8% | $774K |
| SG&A Expenses | $1.2M+30.6% | $922K-73.6% | $3.5M+118.6% | $1.6M+62.7% | $982K-44.2% | $1.8M+138.7% | $737K0.0% | $737K |
| Operating Income | -$1.3M-22.9% | -$1.0M+73.7% | -$3.9M-93.7% | -$2.0M-41.7% | -$1.4M+74.6% | -$5.6M-289.6% | -$1.4M-1.2% | -$1.4M |
| Interest Expense | $5K-42.2% | $9K+56.2% | $6K-3.9% | $6K+126.5% | $3K-73.9% | $10K+142.6% | $4K-19.7% | $5K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$1.2M-28.3% | -$968K+75.0% | -$3.9M-93.6% | -$2.0M-44.0% | -$1.4M+74.8% | -$5.5M-304.8% | -$1.4M+20.1% | -$1.7M |
| EPS (Diluted) | $-0.10 | N/A | $-0.32+84.9% | $-2.12-1666.7% | $-0.12 | N/A | $-0.12+20.0% | $-0.15 |
NTRBW Balance Sheet
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.9M-8.7% | $7.5M-10.3% | $8.4M-17.3% | $10.2M+65.4% | $6.2M-17.6% | $7.5M-40.4% | $12.5M-8.0% | $13.6M |
| Current Assets | $4.4M-12.3% | $5.0M-14.2% | $5.8M-22.7% | $7.5M+119.3% | $3.4M-28.5% | $4.8M-22.6% | $6.2M-14.6% | $7.2M |
| Cash & Equivalents | $4.0M-12.4% | $4.6M-13.9% | $5.3M-24.1% | $7.0M+136.0% | $3.0M-31.3% | $4.3M-24.3% | $5.7M-15.7% | $6.8M |
| Inventory | $121K+3.0% | $118K-13.2% | $136K-1.5% | $138K-35.9% | $215K+1.5% | $212K+26.0% | $168K-24.8% | $224K |
| Accounts Receivable | $3K-97.8% | $118K-19.8% | $148K-8.2% | $161K+70.8% | $94K+27.5% | $74K-32.6% | $110K+61.2% | $68K |
| Goodwill | $1.7M0.0% | $1.7M0.0% | $1.7M0.0% | $1.7M0.0% | $1.7M0.0% | $1.7M-65.8% | $5.0M0.0% | $5.0M |
| Total Liabilities | $902K+3.9% | $868K-0.2% | $870K-48.3% | $1.7M+60.4% | $1.0M+0.7% | $1.0M-20.6% | $1.3M+11.8% | $1.2M |
| Current Liabilities | $832K+6.1% | $784K+1.5% | $773K-50.9% | $1.6M+69.9% | $925K-5.9% | $983K-21.2% | $1.2M+13.1% | $1.1M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $6.0M-10.3% | $6.7M-11.5% | $7.5M-11.1% | $8.5M+66.4% | $5.1M-20.6% | $6.4M-42.8% | $11.2M-9.9% | $12.5M |
| Retained Earnings | -$47.9M-2.7% | -$46.7M-2.1% | -$45.7M-9.3% | -$41.9M-5.0% | -$39.9M-3.6% | -$38.5M-16.7% | -$32.9M-4.3% | -$31.6M |
NTRBW Cash Flow Statement
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$563K+23.1% | -$732K+58.2% | -$1.8M-33.4% | -$1.3M+1.8% | -$1.3M-7.9% | -$1.2M-22.7% | -$1.0M+34.6% | -$1.5M |
| Capital Expenditures | N/A | $0 | $0 | $0-100.0% | $5K | $0-100.0% | $47K+20.7% | $39K |
| Free Cash Flow | N/A | -$732K+58.2% | -$1.8M-33.4% | -$1.3M+2.2% | -$1.3M-8.3% | -$1.2M-17.3% | -$1.1M+33.2% | -$1.6M |
| Investing Cash Flow | N/A | $0 | $0 | $0+100.0% | -$5K | $0+100.0% | -$47K-20.7% | -$39K |
| Financing Cash Flow | -$6K-1.4% | -$5K-107.9% | $70K-98.7% | $5.3M+100482.1% | -$5K+96.4% | -$147K-2744.9% | -$5K-0.8% | -$5K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NTRBW Financial Ratios
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.4%+23.2pp | 22.2%+2.4pp | 19.8%-5.4pp | 25.2%-12.6pp | 37.8%-6.8pp | 44.5%+14.9pp | 29.6%+6.7pp | 22.9% |
| Operating Margin | -289.4%-34.6pp | -254.8%+866.5pp | -1121.3%-799.5pp | -321.8%-110.1pp | -211.8%+653.6pp | -865.3%-644.4pp | -220.9%+97.4pp | -318.4% |
| Net Margin | -286.6%-45.0pp | -241.6%+877.4pp | -1119.0%-797.6pp | -321.4%-113.3pp | -208.1%+650.7pp | -858.8%-647.8pp | -211.0%+174.1pp | -385.1% |
| Return on Equity | -20.7%-6.2pp | -14.5%+36.8pp | -51.3%-27.8pp | -23.5%+3.7pp | -27.2%+58.6pp | -85.8%-73.7pp | -12.1%+1.6pp | -13.7% |
| Return on Assets | -18.0%-5.2pp | -12.8%+33.2pp | -46.0%-26.3pp | -19.7%+2.9pp | -22.6%+51.3pp | -73.9%-63.0pp | -10.9%+1.6pp | -12.5% |
| Current Ratio | 5.26-1.1 | 6.36-1.2 | 7.53+2.7 | 4.78+1.1 | 3.71-1.2 | 4.88-0.1 | 4.96-1.6 | 6.57 |
| Debt-to-Equity | 0.15+0.0 | 0.13+0.0 | 0.12-0.1 | 0.200.0 | 0.21+0.0 | 0.16+0.0 | 0.12+0.0 | 0.09 |
| FCF Margin | N/A | -182.6%+323.8pp | -506.4%-295.4pp | -211.0%-9.9pp | -201.1%-8.2pp | -192.9%-29.3pp | -163.6%+193.8pp | -357.4% |
Similar Companies
Frequently Asked Questions
What is Nutriband's annual revenue?
Nutriband (NTRBW) reported $2.0M in total revenue for fiscal year 2026. This represents a -4.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nutriband's revenue growing?
Nutriband (NTRBW) revenue declined by 4.8% year-over-year, from $2.1M to $2.0M in fiscal year 2026.
Is Nutriband profitable?
No, Nutriband (NTRBW) reported a net income of -$8.2M in fiscal year 2026, with a net profit margin of -404.1%.
What is Nutriband's EBITDA?
Nutriband (NTRBW) had EBITDA of -$8.1M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Nutriband's gross margin?
Nutriband (NTRBW) had a gross margin of 27.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nutriband's operating margin?
Nutriband (NTRBW) had an operating margin of -408.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Nutriband's net profit margin?
Nutriband (NTRBW) had a net profit margin of -404.1% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Nutriband's return on equity (ROE)?
Nutriband (NTRBW) has a return on equity of -137.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Nutriband's free cash flow?
Nutriband (NTRBW) generated -$5.1M in free cash flow during fiscal year 2026. This represents a -8.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Nutriband's operating cash flow?
Nutriband (NTRBW) generated -$5.1M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Nutriband's total assets?
Nutriband (NTRBW) had $6.9M in total assets as of fiscal year 2026, including both current and long-term assets.
What are Nutriband's capital expenditures?
Nutriband (NTRBW) invested $5K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Nutriband spend on research and development?
Nutriband (NTRBW) invested $1.9M in research and development during fiscal year 2026.
What is Nutriband's current ratio?
Nutriband (NTRBW) had a current ratio of 5.26 as of fiscal year 2026, which is generally considered healthy.
What is Nutriband's debt-to-equity ratio?
Nutriband (NTRBW) had a debt-to-equity ratio of 0.15 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nutriband's return on assets (ROA)?
Nutriband (NTRBW) had a return on assets of -119.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Nutriband's cash runway?
Based on fiscal year 2026 data, Nutriband (NTRBW) had $4.0M in cash against an annual operating cash burn of $5.1M. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Nutriband's Piotroski F-Score?
Nutriband (NTRBW) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nutriband's earnings high quality?
Nutriband (NTRBW) has an earnings quality ratio of 0.62x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Nutriband cover its interest payments?
Nutriband (NTRBW) has an interest coverage ratio of -369.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Nutriband?
Nutriband (NTRBW) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.